Abstract
Background: Studies have shown that many drugs have a lower effectiveness in clinical practice than would be expected from results reported in randomised controlled clinical trials. Many factors influence the use of drugs. Personal factors such as knowledge, attitudes, motivation, expectations are considered to be of particular consequence. The aim of the study was to analyse attitudes towards drugs from an epidemiological perspective.Design: Cross-sectional surveySetting:The county of Uppsala, Sweden, 1995.Results: 5,404 completed the questionnaire (response rate=68%). A majority either considered drugs as something positive, a help (60%), or as something necessary but evil (38%). A small proportion — around 2% — considered drugs as a danger. There were differences in attitudes according to education and income, self-care orientation, medication knowledge, and state of health. We also found differences in attitudes between users and non-users of certain types of drugs. Users of hypertensive drugs more often considered drugs as necessary but evil than did non-users of these drugs, while users of psychotropic drugs more often viewed drugs as something positive than did patients who did not use psychotropic drugs.Conclusion: A better understanding of the general attitudes towards drugs is important when giving both written and oral information to patients and to the public at large. It is also important to be aware of differences in attitudes between various patient groups and that certain patients, e.g., patients prescribed hypertensive drugs, could require more attention from health care professionals.
Similar content being viewed by others
References
Revicki D, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. PharmacoEconomics 1999;15:423–34.
Avorn J. The prescription as final common pathway. In J Technol Assess Health Care 1995;11:384–90.
Lindström E, Bingefors K. Patient compliance with drug therapy in schizophrenia. Economic and clinical issues. Pharmaco-Economics 2000;18:105–24.
DiMatteo MR, DiNicola DD. Achieving patient compliance. The psychology of the medical practitioner's role. New York, Oxford, Toronto, Sydney, Paris, Frankfurt: Pergamon Press; 1982.
Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH, Taylor DW. Patient perception and compliance: Recent studies of the Health Belief Model. In: Haynes RB, Taylor D, W., Sackett DL, editors. Compliance in health care. Baltimore and London: The John Hopkins University Press; 1979. p. 78–109.
Strecher VJ, Rosenstock IM. The Health Belief Model. In: Glanz K, Lewis FM, Rimer BK, editors. Health behavior and health education. 2nd ed. San Fransisco: Jossey-Bass Publishers; 1996. p. 41–59.
Fishbein M, Ajzen I. Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, Massachusetts: Addison-Weseley; 1975.
Montano DE, Kaspryzyk D, Taplin HT. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Lewis FM, Rimer BK, editors. Health behavior and health education. San Fransisco: Jossey-Bass Publishers; 1996. p. 85–112.
Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter. J Health Soc Behav 1995;36:1–10.
Ajzen I. Nature and operation of attitudes. Ann Rev Psychol 2001;52:27–58.
Jarvis W, Petty R. The need to evaluate. J Pers Soc Psychol 1996;70:172–94.
Petty R, Wegener D, Fabrigar L. Attitudes and attitude change. Ann Rev Psychol 1997;48:609–47.
Cleary P, Mechanic D, Greenley J. Sex differences in medical care utilization: An empirical investigation. J Health Soc Behav 1982;23:106–19.
Meininger J. Sex differences in factors associated with use of medical care and alternative illness behaviors. Soc Sci Med 1986;22:285–92.
Fiscella K, Franks P, Clancy C. Skepticism toward medical care and health care utilization. Med Care 1998;36:180–9.
Fallsberg M. Reflections on medicines and medication-a qualitative analysis among people on long-term regimens (Thesis). Linköping University: Department of Education and Psychology; 1991.
Lisper L, Isacson D, Sjödèn P, Bingefors K. Medicated hypertensive patients' view and experience of information and communication concerning antihypertensive drugs. Patient Educ Couns 1997;32:147–55.
Antonov K. Pharmacoepidemiological studies on the use of analgesics in Sweden. Uppsala: Acta. Univ. Ups. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy; 1997.
Statistics Sweden. Living Conditions. Appendix 13. Technical report for 1984-85, 1986-87 and 1988-89 years Surveys of Living Conditions. Örebro: SCB-tryck; 1991.
Statistics Sweden. Living Conditions. Report no 76. Health and medical care 1980-1989. Örebro: SCB-tryck; 1992.
Thorslund M, Wärneryd B. Methodological research in the Swedish Surveys of Living Conditions. Problems of measurements and data collection. Soc Ind Res 1985;16:77–95.
SAS Institute Inc. The SAS system for windows, Release 6.12. Cary,NC, USA; 1989-96.
BMDP Statistical Software Version 7.0. Berkeley, CA.: University of California Press; 1992.
Verbrugge L. Gender and health: an update on hypothesis and evidence. J Health Soc Behav 1985;1985:156–82.
Isacson D. Pharmacological patterns among heavy users of prescription drugs. J Soc Adm Pharm 1987;5:12–20.
Svarstad B, Cleary P. Gender differences in the acquisition of prescribed drugs: An epidemiological study. Med Care 1987;25:1089–98.
Dowell J, Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract 1997;14:369–75.
Lowe C, Raynor D, Courtney E, Purvis J, Teale C. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ 1995;310:1229–31.
Burke L, Dunbar J, Hill M. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19:239–63.
Cramer J, Scheyer R, Mattson R. Compliance decline between clinic visits. Arch Int Med 1990;150:1509–10.
Balter M, Manheimer D, Mellinger G, Uhlenhuth E. A crosssectional comparison of anti-anxiety/sedative drug use. Curr Med Res Opin 1984;8(Suppl. 4):5–20.
Mellinger G, Balter M, Uhlenhuth E. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251:375–9.
Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time-a 13 year follow-up in a Swedish community. Soc Sci Med 1997;44:1871–80.
Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig S, Weissbecker H, et al. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 1997;185:151–8.
Hillert A, Sandmann J, Ehmig S, Weisbecker H, Sobota K, Kepplinger H, et al. Psychopharmacological drugs as represented in the press. Results of a systematic analysis of newspapers and popular magazines. Pharmacopsychiat 1996;29:67–71.
Manheimer D, Davidson S, Balter M, Mellinger G, Cisin H, Perry H. Popular attitudes and beliefs about tranquillizers. Am J Psychiatry 1973;130:1246–53.
Angermeyer M, Däumer R, Matschinger H. Benefits and risks of psychotropic medication in the eyes of the general population: results of a survey in the Federal republic of Germany. Pharmacopsychiat 1993;26:114–20.
Priest R, Vize C, Roberts A, Roberts M. Lay people´s attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BMJ 1996;313:858–9.
Paykel E, Hart D, Priest R. Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psych 1998;173:519–22.
Ruscher S, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr Serv 1997;48:82–5.
Genazzani A, M. G. Hormone replacement therapy: the perspectives for the 21st centry. Maturitas 1999;32:11–7.
Colditz G. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone therapy. J Womens Health 1999;8:347–57.
Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol 1999;180:S343–8.
Lewis M. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives. Am J Obstet Gynecol 1998;179:S68–77.
Zeitoun K, Carr B. Is there an increased risk of stroke associated with oral contraceptives. Drug Saf 1999;20:467–73.
Committee on Safety of Medicines. Combined oral contraceptives and thromboembolism. London: CSM; 1995.
Farmer R, Williams T, Simpson E, Nightingale A. Effect of 1995 pill scare on rates of venous thromboembolism among women taking oral contraceptives: analysis of General Practice Database. BMJ 2000;321:477–9.
Tyden T, Bingefors K, Odlind V. Oral contraceptives and compliance: reaction to cardiovascular alarm among users. Adv Contracept 1999;15:133–9.
Mattsson L, Stadberg E, Milsom I. Management of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl 1):S3–S5.
Barentsen R. The climacteric in the Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl 1):S7–S11.
Hammar M, Bryhildsen J, Dabrosin L, Frisk J, Lindgren R, Nedstrand E, et al. Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 1996;25:193–9.
Astin J. Why patients use alternative medicine: results from a national study. JAMA 1998;279:1548–3.
Holland J. Use of alternative medicine-a marker for distress. New Engl J Med 1999;340:1758–9.
Siahpush M. Why do people favour alternative medicine. Aust NZJ Med 1999;23:266–71.
Furnham A, Bhagrath R. A comparison of health beliefs and behaviours of clients of orthodox and complementary medicine. Br J Clin Psychol 1993;32:237–46.
Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley; 1987.
Petty R, Krosnick J, editors. Attitude strength: Antecedents and consequences. Mahwah NJ: Erlbaum; 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Isacson, D., Bingefors, K. Attitudes towards drugs — a survey in the general population. Pharm World Sci 24, 104–110 (2002). https://doi.org/10.1023/A:1016127320051
Issue Date:
DOI: https://doi.org/10.1023/A:1016127320051